Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Spire Healthcare Group plc
  6. News
  7. Summary
    SPI   GB00BNLPYF73

SPIRE HEALTHCARE GROUP PLC

(SPI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Spire Healthcare : delays vote on £1bn Ramsay takeover as investors voice concerns

07/07/2021 | 04:22am EDT

The waiting list is growing longer at private hospitals group Spire Healthcare, which today delayed the vote on its £1bn takeover by Ramsay Health Care.

The short interval, it explained, was because “a number of investors have requested a short extension to the process to allow them to exercise voting rights”.

Shares are down more than 3.5 per cent this morning to 229p.

Ramsay this week topped up the offer from 240p per share to 250p per share, but investors such as Toscafund and Fidelity said the deal still undervalues the private hospitals business.

They think the increasing pressures on the NHS will prove beneficial to the private healthcare sector.

Proxy investor group Glass Lewis over the weekend said: “We do not believe the proposed transaction provides sufficiently compelling value relative to Spire’s business prospects, assets and current trading level.

“We do not believe the proposed transaction is in the best interests of Spire shareholders at this time.”

This morning Sir Ian Cheshire, Chairman of Spire, said: The Spire Board respects the views of all shareholders and it is incumbent on us to ensure the voting process is fair and open to all.  A number of investors have requested a short extension to the process to allow them to exercise voting rights, and it is our responsibility to ensure that as many shareholders as possible have the opportunity to express their views.

“We urge all shareholders to take advantage of this extension and remind them of the Spire Board’s previous unanimous recommendation to vote in favour of the proposal from Ramsay,” he added.

Voting will now take place on 15 July, with a general meeting on 19 July.

The post Spire Healthcare delays vote on £1bn Ramsay takeover as investors voice concerns appeared first on CityAM.

© City AM, source Newspaper

Stocks mentioned in the article
ChangeLast1st jan.
RAMSAY HEALTH CARE LIMITED 0.98% 70.06 End-of-day quote.12.67%
SPIRE HEALTHCARE GROUP PLC 1.89% 243 Delayed Quote.56.37%
All news about SPIRE HEALTHCARE GROUP PLC
09/14SPIRE HEALTHCARE : Southampton Hospital maintains CQC rating as 'Good'
PU
09/10SPIRE HEALTHCARE : Barclays Upgrades Spire Healthcare To Overweight, Raises PT
MT
09/09FTSE 100 Retreats Again as Travel, Retail Stocks Fall
DJ
09/09SPIRE HEALTHCARE : Narrows H1 Loss On Strong Operating Profit
MT
09/09Spire Healthcare Group to Seek Acquisitions
CI
09/09Houlihan Lokey raises offer for Japan M&A advisory firm
RE
09/09SPIRE HEALTHCARE : Half year results supporting document
PU
09/09Houlihan Lokey raises offer for Japan M&A advisory firm
RE
09/09SPIRE HEALTHCARE : returns to operating profit amid climbing Covid costs
AQ
09/09SPIRE HEALTHCARE : Earnings Flash (SPI.L) SPIRE HEALTHCARE GROUP Posts H1 Loss G..
MT
More news
Analyst Recommendations on SPIRE HEALTHCARE GROUP PLC
More recommendations
Financials
Sales 2021 1 074 M 1 476 M 1 476 M
Net income 2021 19,6 M 26,9 M 26,9 M
Net Debt 2021 1 061 M 1 457 M 1 457 M
P/E ratio 2021 50,0x
Yield 2021 0,21%
Capitalization 974 M 1 340 M 1 338 M
EV / Sales 2021 1,89x
EV / Sales 2022 1,80x
Nbr of Employees 11 943
Free-Float 67,9%
Chart SPIRE HEALTHCARE GROUP PLC
Duration : Period :
Spire Healthcare Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SPIRE HEALTHCARE GROUP PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Last Close Price 243,00 GBX
Average target price 247,00 GBX
Spread / Average Target 1,65%
EPS Revisions
Managers and Directors
Justinian Joseph Ash Chief Executive Officer & Executive Director
Jitesh Himatlal Sodha Chief Financial Officer & Executive Director
Ian Michael Cheshire Chairman
Alison Dickinson Group Clinical Director
Fergus Macpherson Group Medical Director
Sector and Competitors